News

Top Morgan Stanley Picks to Watch for Future Growth Potential

Top Morgan Stanley Picks to Watch for Future Growth Potential

Leading Stock Picks from Morgan Stanley

Morgan Stanley stands out as a prominent name among Wall Street investment banks, successfully navigating the complexities of financial markets. Its robust investment banking segment generated significant revenue recently, showcasing its influence in equity coverage. This article highlights three standout stocks currently favored by Morgan Stanley's analysts, reflecting their insights about future growth.

1. Seagate: Capitalizing on Growing Data Needs

Starting off the list is Seagate Technology (NASDAQ: STX). Morgan Stanley projects a price target of $129 for the company, indicating a potential 25% increase from current stock prices. Seagate has established itself as a leading producer of hard disk drives (HDDs), crucial for data storage across various applications.

HDDs can hold vast amounts of data affordably compared to solid-state drives (SSDs). Despite being slower, HDDs are ideal for scenarios where rapid data access isn't necessary, such as backups and long-term storage of records.

Following a robust earnings report for fiscal Q2 2025, Morgan Stanley heightened its expectations for Seagate's stock. The company exceeded earnings estimates, showcasing strong demand aligned with the increasing importance of data storage, particularly amid rising artificial intelligence applications. CEO William Mosely emphasized the vital role of HDDs in managing large datasets required for AI training, showcasing their essential function in modern data management.

Furthermore, Seagate's HDD revenue surged by 57% year-over-year, with mass capacity devices now comprising 87% of sales. This upward trend suggests growing reliance from large-scale data needs as AI technologies continue to evolve, warranting close attention from analysts.

2. Robinhood: Riding the Crypto Wave

Next on the radar is Robinhood Markets (NASDAQ: HOOD), recently added to Morgan Stanley's esteemed “Financials’ Finest” list. The firm has elevated its price target for Robinhood to $64, implying a compelling 34% upside. The platform has seen a remarkable uptick of over 75% in share price recently, attributed in part to favorable political circumstances that observers expect will benefit the cryptocurrency industry.

Analysis revealed that close to 48% of corporate donations to Trump’s election campaign stem from cryptocurrency businesses, hinting at broad support for policies benefiting this sector. Additionally, executive initiatives aimed at enhancing America's digital financial technology could foster significant growth within Robinhood's crypto trading venture.

Given that profits from crypto transactions constitute a substantial part of Robinhood’s earnings—totaling $311 million in the last four quarters—a pro-crypto administration could amplify trading activity, thereby significantly boosting revenues. With opportunities for international expansion and diversified offerings such as retirement accounts, the company appears well-positioned for future growth.

3. Atlassian: Harnessing Cloud Technology

Lastly, we have Atlassian (NASDAQ: TEAM). Morgan Stanley maintains an overweight rating on this tech stock, eyeing a price target of $315, equating to nearly 18% growth potential. Atlassian, renowned for its productivity software, aims to enhance workplace collaboration and efficiency.

Recent bullish outlooks stem from the unveiling of Rovo, a new Generative AI tool designed to promote growth while assisting customer migration to cloud services. Rovo enables users to seamlessly search through Atlassian platforms and associated applications while interacting with a bot tailored to their specific organizational needs.

By shifting its customer base towards cloud solutions, Atlassian shows potential for increased profitability. This migration not only facilitates easier updates but also enhances the company's capacity to cross-sell additional services. Currently, data center deployment accounts for 67% of its revenue, highlighting the substantial growth prospects adjacent to cloud services.

Furthermore, with Atlassian's market penetration sitting at less than 7% of its targeted $67 billion sector, there are encouraging indicators of untapped opportunity and continued expansion ahead.

Frequently Asked Questions

What are Morgan Stanley's top stock picks?

Morgan Stanley's current top picks include Seagate Technology, Robinhood Markets, and Atlassian, each showing significant growth potential.

Why is Seagate favored by Morgan Stanley analysts?

Seagate is backed by its impressive revenue growth from HDDs driven by rising data storage needs, essential for modern technologies, especially AI.

How does political influence affect Robinhood's prospects?

Robinhood's favorable position is attributed to anticipated pro-crypto policies under the new administration, potentially boosting trading volumes and revenues.

What is Atlassian’s growth strategy?

Atlassian is focused on cloud migration and the introduction of AI tools like Rovo to enhance customer engagement and drive revenue growth.

What is the target market for Atlassian's services?

Atlassian targets a substantial market valued at $67 billion with significant room for growth as its penetration remains low.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gateway Unveils All-In-One Award Travel Platform

Updated Category News Views 6

Transforming Loyalty with point.me's Gateway Here's the deal: the loyalty program game just changed. Point.me rolled out this slick beast called Gateway, and it's weaving award travel booking right into your everyday banking apps. That's right, ditch those clunky third-party sites, because now you can browse, compare, transfer, and book your award travel directly from...

Continue Reading
Ace Hardware Ups the Stakes with Rewards Days Event

Updated Category News Views 2

Ace Hardware: Doubling Down with Rewards Ace Hardware's rolling out the red carpet for its loyal customers. Imagine this: exclusive deals on trusted brands and double points on purchases—an incentive any savvy shopper would jump at. From October 6 to 7, those in the Ace Rewards circle have the chance to nab some hefty savings and perks, a move that's more than just a...

Continue Reading
Maternal Health Index: A New Tool With Big Ambitions

Updated Category News Views 3

A Fresh Take on Maternal Health Today's all about the Heartland Forward's fresh tool, the Maternal Resiliency Index. It's making a splash at the 2026 Heartland Summit with a lot of promise on its shoulders. Backed by economists and health gurus like Emily Oster and Dr. Neel Shah, this index ain't your run-of-the-mill tool. It's here to shake the couch coins out of...

Continue Reading
Haystack MRD Shines in Colorectal Cancer Trials

Updated Category News Views 4

A New Dawn in Cancer Detection Just when you think you've seen it all in cancer diagnostics, Haystack MRD® pops up like a fresh tulip in spring. And listen, this ain't just fluff—the results from the DYNAMIC trials are a pretty compelling love letter to the power of liquid biopsy. With 100% specificity and sensitivity hitting a whopping 83.3% over five years, it’s...

Continue Reading
Hyundai's Record Q3 Sales: SUVs and Hybrids Lead

Updated Category News Views 3

Hyundai's Drive to Record Q3 Sales When talking about market moves, Hyundai's recent figures speak louder than most quarterly bells. September 2026 marked a whirlwind of growth for Hyundai Motor America, reporting record-breaking sales numbers not just for the month, but for Q3 as a whole. With a 9% jump from September last year in total vehicle sales and a remarkable 3%...

Continue Reading
Li-Fire Expands Fire Safety Amid Rising Battery Risks

Updated Category News Views 7

A Crunchy Look at New Fire Safety Moves Well, folks, here's a twist we didn't see coming but sure makes sense in today's electrifying business landscape. Li-Fire, the big brains behind lithium battery fire suppression, is spreading its wings nationwide, or at least its wholesale and distribution programs are. And right ahead of National Fire Safety Week no less—talk...

Continue Reading
Texas A&M-San Antonio's Research Expansion Momentum

Updated Category News Views 4

Texas A&M-San Antonio's Rising Research Ambitions A rainy day in San Antonio and Texas A&M University-San Antonio seems to have set the stage for more than just another semester of record enrollment. They’ve just rolled in with an exhilarating $8 million in external grants this fiscal year, more than doubling last year’s haul of $3.6 million, in a bid to push their...

Continue Reading
Ultrabench Revolutionizes AI Model Comparison Game

Updated Category News Views 3

Breaking Down the Messy AI Model Landscape Ultrabench.ai is here to drag AI model comparison out of the dark ages. Picture this: 309 AI models, ranked against a whopping 530 benchmarks, all served up on one plate. If you’re navigating the AI jungle, you’ll realize how Ultrabench is no small fish in this vast ocean. Consolidating Where Others Have Scattered There's a...

Continue Reading
MiniCo's New Desk: A Game Changer for E&S Market

Updated Category News Views 4

A New Chapter in Industrial Casualty Look out, folks! MiniCo Insurance Agency is making waves with its latest launch. They're teaming up with Lloyd's of London, not to sell fish and chips, but to bring something groundbreaking in the insurance space—an industrial casualty trading desk. And if you’re raising an eyebrow wondering why this matters, let me break it down...

Continue Reading
Neutonic Sets Sights on U.S. with Walmart Expansion

Updated Category News Views 10

Neutonic Embarks on Major Expansion with Walmart Well, here we go. Neutonic is stepping up to the big leagues by planting its flag in nearly 1,000 Walmart stores across the U.S. This move lands them right in the thrumming heart of Walmart's new Mood & Mind beverage set. It's about time this brand brings its functional beverages to American shoppers already drained by...

Continue Reading

Top 5 Most Recently Viewed Articles

Old Dominion National Bank Enhances Deposit Strategy with CD Valet

Updated Category News Views 213

Old Dominion National Bank Elevates Deposit Growth Strategy In a move that showcases innovation in the financial sector, Old Dominion National Bank (ODNB) is harnessing the power of CD Valet, a digital marketplace designed to enhance deposit acquisition. Both institutions are set to share their success story at a prestigious banking event, underscoring the effectiveness...

Continue Reading
Ascletis' ASC30 Shows Promising Pharmacokinetics for Weight Loss

Updated Category News Views 159

Introduction to ASC30 Oral Tablet Ascletis Pharma Inc. is making waves in the world of biotechnology with its innovative ASC30 oral once-daily tablet. This investigational drug is designed to help manage weight and has shown remarkable pharmacokinetic properties. In recent studies, ASC30 has demonstrated drug exposure levels significantly higher than its counterpart,...

Continue Reading
Global Blood Pressure Monitors Market Trends and Insights

Updated Category News Views 177

Blood Pressure Monitors Market Size & Growth Analysis In recent studies, the blood pressure monitors market has emerged as a crucial segment within the healthcare industry, with estimates indicating a significant increase in market size from USD 1.81 billion in 2023 to an impressive USD 4.28 billion by 2032. This growth reflects a compound annual growth rate (CAGR) of...

Continue Reading
Breakthrough Studies Reveal Insights into Tumor Biology and Cancer Development

Updated Category News Views 326

New Discoveries in Tumor Biology from NIH-Funded Research A collection of recent scientific papers sheds light on critical advancements made by the Human Tumor Atlas Network, part of the innovative efforts under the Cancer Moonshot initiative. Understanding Tumor Development Through Innovative Studies Recent findings from a series of studies uncover how cancer tumors...

Continue Reading
Strengthening Cooperation Against Corruption: A Regional Commitment

Updated Category News Views 263

Strengthening Cooperation Against Corruption: A Regional Commitment Chinese prosecutors are intensifying collaboration with their counterparts from ASEAN member states to tackle corruption and cross-border financial crimes. This strategic move aims to confront emerging crime challenges and enhance regional security, as highlighted by China's top prosecutor in recent...

Continue Reading